BIENAIME JEAN JACQUES — SEC insider filings

SEC reporting owner CIK 1221590. 86 insider filings on record with FilingPulse; latest filed 2026-09-28.

Transaction summary — filings shown

Covers the 50 most recent of 86 filings on record, filed 2023-02-14 to 2026-09-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)Director20—27 legs · 307,000 sh · $28,506,10962
Immunome Inc. (IMNM)Director1211 legs · 46,300 sh · $641,2322 legs · 10,500 sh · $203,8204
Ascendis Pharma A/S (ASND)Director47 legs · 2,900 sh · $699,336—2
Keros Therapeutics, Inc. (KROS)Director96 legs · 7,000 sh · $75,770—5
INCYTE CORP (INCY)Director5——11

Insider filings — BIENAIME JEAN JACQUES

FiledFormIssuerReported transactionsSource
2026-09-284Ascendis Pharma A/S (ASND)Disposition to issuer (D): 9,160 (derivative) · Grant/award (A): 9,160 (derivative)EDGAR
2026-08-194Keros Therapeutics, Inc. (KROS)Purchase (P): 1,000 @ $10.27EDGAR
2026-08-184Ascendis Pharma A/S (ASND)Purchase (P): 1,100 @ $245.85 · Purchase (P): 900 @ $246.91EDGAR
2026-07-174Keros Therapeutics, Inc. (KROS)Purchase (P): 1,000 @ $10.61EDGAR
2026-06-174Keros Therapeutics, Inc. (KROS)Purchase (P): 1,000 @ $10.19EDGAR
2026-06-124Immunome Inc. (IMNM)Grant/award (A): 9,897 (derivative) @ $0EDGAR
2026-06-104INCYTE CORP (INCY)Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0EDGAR
2026-06-094Immunome Inc. (IMNM)Sale (S): 500 @ $19.44 · Sale (S): 10,000 @ $19.41 · Purchase (P): 6,000 @ $19.48 · Purchase (P): 3,500 @ $19.46 · Purchase (P): 1,000 @ $19.27EDGAR
2026-06-054Keros Therapeutics, Inc. (KROS)Grant/award (A): 7,142 @ $0 · Grant/award (A): 7,433 (derivative) @ $0EDGAR
2026-06-014Ascendis Pharma A/S (ASND)Purchase (P): 200 @ $223.76 · Purchase (P): 200 @ $222.30 · Purchase (P): 100 @ $223.50EDGAR
2026-05-284INCYTE CORP (INCY)Option exercise (M): 15,000 @ $84.53 · Tax withholding (F): 13,059 @ $97.10 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-05-274Ascendis Pharma A/S (ASND)Purchase (P): 200 @ $236.24 · Purchase (P): 200 @ $239.37EDGAR
2026-05-194Immunome Inc. (IMNM)Purchase (P): 5,000 @ $20.70EDGAR
2026-05-194Keros Therapeutics, Inc. (KROS)Purchase (P): 1,000 @ $10.58EDGAR
2026-04-174Keros Therapeutics, Inc. (KROS)Purchase (P): 1,000 @ $11.70EDGAR
2026-03-124Immunome Inc. (IMNM)Purchase (P): 1,000 @ $22.12 · Purchase (P): 1,000 @ $21.55EDGAR
2026-03-114Keros Therapeutics, Inc. (KROS)Purchase (P): 2,000 @ $11.21EDGAR
2025-06-124Immunome Inc. (IMNM)Grant/award (A): 18,864 (derivative) @ $0EDGAR
2025-06-124INCYTE CORP (INCY)Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0EDGAR
2025-06-064Keros Therapeutics, Inc. (KROS)Grant/award (A): 5,250 @ $0 · Grant/award (A): 10,500 (derivative) @ $0EDGAR
2025-06-034Immunome Inc. (IMNM)Purchase (P): 5,000 @ $9.38EDGAR
2025-03-264Immunome Inc. (IMNM)Purchase (P): 7,800 @ $7.78EDGAR
2025-03-254Immunome Inc. (IMNM)Purchase (P): 7,000 @ $8.21EDGAR
2024-08-194Immunome Inc. (IMNM)Purchase (P): 7,000 @ $13.94EDGAR
2024-06-184Immunome Inc. (IMNM)Grant/award (A): 11,333 (derivative) @ $0EDGAR
2024-06-144INCYTE CORP (INCY)Grant/award (A): 2,830 @ $0 · Grant/award (A): 12,517 (derivative) @ $0EDGAR
2024-06-054Keros Therapeutics, Inc. (KROS)Grant/award (A): 17,600 (derivative) @ $0EDGAR
2024-05-224Immunome Inc. (IMNM)Purchase (P): 2,000 @ $13.57EDGAR
2024-05-214BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 1,202 @ $77.05EDGAR
2024-05-134BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 20,000 @ $63.10 · Sale (S): 20,000 @ $81.62 · Option exercise (M): 20,000 @ $63.10 · Sale (S): 20,000 @ $81.14 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-04-154BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 20,000 @ $63.10 · Sale (S): 20,000 @ $90.99 · Option exercise (M): 20,000 @ $63.10 · Sale (S): 20,000 @ $91.26 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 85,209 @ $83.87EDGAR
2024-03-074BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,000 @ $85.51 · Sale (S): 1,000 @ $86.71EDGAR
2024-02-294BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 82,700 @ $0 · Grant/award (A): 35,975 @ $0 · Grant/award (A): 24,926 @ $0 · Sale (S): 1,000 @ $90.35EDGAR
2024-02-124BIOMARIN PHARMACEUTICAL INC (BMRN)Code (L): 40 @ $92.60 · Option exercise (M): 15,000 @ $63.10 · Sale (S): 15,000 @ $89.77 · Option exercise (M): 15,000 @ $63.10 · Sale (S): 15,000 @ $88.28 · Option exercise (M): 15,000 (derivative) @ $0 · +1 moreEDGAR
2024-01-114BIOMARIN PHARMACEUTICAL INC (BMRN)Code (L): 50 @ $99.05 · Option exercise (M): 10,000 @ $63.10 · Sale (S): 10,000 @ $98.19 · Option exercise (M): 10,000 @ $63.10 · Sale (S): 10,000 @ $96.38 · Option exercise (M): 10,000 (derivative) @ $0 · +1 moreEDGAR
2023-12-224BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 10,000 @ $63.10 · Sale (S): 10,000 @ $93.99 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-12-124BIOMARIN PHARMACEUTICAL INC (BMRN)Code (L): 10 @ $85.57 · Grant/award (A): 2,370 @ $0EDGAR
2023-11-094Immunome Inc. (IMNM)Grant/award (A): 40,696 (derivative) @ $0EDGAR
2023-08-094BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 4,000 @ $88.10 · Sale (S): 6,000 @ $88.29EDGAR
2023-06-164INCYTE CORP (INCY)Grant/award (A): 2,505 @ $0 · Grant/award (A): 11,294 (derivative) @ $0EDGAR
2023-05-164BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 39,130 @ $67.81 · Option exercise (M): 7,370 @ $67.81 · Tax withholding (F): 6,337 @ $93.93 · Tax withholding (F): 33,644 @ $93.93 · Option exercise (M): 39,130 (derivative) @ $0 · Option exercise (M): 7,370 (derivative) @ $0EDGAR
2023-05-154BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 30,000 @ $67.81 · Sale (S): 24,439 @ $94.55 · Sale (S): 5,561 @ $95.22 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2023-05-114BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 317 @ $66.88 · Option exercise (M): 30,000 @ $67.81 · Sale (S): 13,626 @ $94.22 · Sale (S): 14,964 @ $95.49 · Sale (S): 1,410 @ $95.90 · Option exercise (M): 30,000 @ $67.81 · +4 moreEDGAR
2023-04-124BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 10,000 @ $67.81 · Sale (S): 10,000 @ $99.56 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-04-104BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 10,000 @ $67.81 · Sale (S): 10,000 @ $96.13 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 36,100 @ $0 · Tax withholding (F): 9,437 @ $87.74 · Tax withholding (F): 88,623 @ $93.41 · Grant/award (A): 49,430 (derivative) @ $0EDGAR
2023-03-144BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 15,000 @ $67.81 · Sale (S): 15,000 @ $92.28 · Option exercise (M): 8,000 @ $67.81 · Sale (S): 8,000 @ $90.45 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2023-03-024BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 89,700 @ $0 · Grant/award (A): 44,860 @ $0 · Grant/award (A): 32,972 @ $0EDGAR
2023-02-144BIOMARIN PHARMACEUTICAL INC (BMRN)Gift (G): 200 @ $0 · Gift (G): 100 @ $0 · Gift (G): 100 @ $0 · Option exercise (M): 15,000 @ $67.81 · Sale (S): 15,000 @ $110.11 · Option exercise (M): 6,000 @ $67.81 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1221590 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs